PMID- 20847403 OWN - NLM STAT- MEDLINE DCOM- 20110309 LR - 20220408 IS - 1875-8908 (Electronic) IS - 1387-2877 (Print) IS - 1387-2877 (Linking) VI - 22 IP - 2 DP - 2010 TI - Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. PG - 569-79 LID - 10.3233/JAD-2010-100768 [doi] AB - Impaired glucose regulation is a defining characteristic of type 2 diabetes mellitus (T2DM) pathology and has been linked to increased risk of cognitive impairment and dementia. Although the benefits of aerobic exercise for physical health are well-documented, exercise effects on cognition have not been examined for older adults with poor glucose regulation associated with prediabetes and early T2DM. Using a randomized controlled design, twenty-eight adults (57-83 y old) meeting 2-h tolerance test criteria for glucose intolerance completed 6 months of aerobic exercise or stretching, which served as the control. The primary cognitive outcomes included measures of executive function (Trails B, Task Switching, Stroop, Self-ordered Pointing Test, and Verbal Fluency). Other outcomes included memory performance (Story Recall, List Learning), measures of cardiorespiratory fitness obtained via maximal-graded exercise treadmill test, glucose disposal during hyperinsulinemic-euglycemic clamp, body fat, and fasting plasma levels of insulin, cortisol, brain-derived neurotrophic factor, insulin-like growth factor-1, amyloid-beta (Abeta40 and Abeta42). Six months of aerobic exercise improved executive function (MANCOVA, p=0.04), cardiorespiratory fitness (MANOVA, p=0.03), and insulin sensitivity (p=0.05). Across all subjects, 6-month changes in cardiorespiratory fitness and insulin sensitivity were positively correlated (p=0.01). For Abeta42, plasma levels tended to decrease for the aerobic group relative to controls (p=0.07). The results of our study using rigorous controlled methodology suggest a cognition-enhancing effect of aerobic exercise for older glucose intolerant adults. Although replication in a larger sample is needed, our findings potentially have important therapeutic implications for a growing number of adults at increased risk of cognitive decline. FAU - Baker, Laura D AU - Baker LD AD - Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA. ldbaker@uw.edu FAU - Frank, Laura L AU - Frank LL FAU - Foster-Schubert, Karen AU - Foster-Schubert K FAU - Green, Pattie S AU - Green PS FAU - Wilkinson, Charles W AU - Wilkinson CW FAU - McTiernan, Anne AU - McTiernan A FAU - Cholerton, Brenna A AU - Cholerton BA FAU - Plymate, Stephen R AU - Plymate SR FAU - Fishel, Mark A AU - Fishel MA FAU - Watson, G Stennis AU - Watson GS FAU - Duncan, Glen E AU - Duncan GE FAU - Mehta, Pankaj D AU - Mehta PD FAU - Craft, Suzanne AU - Craft S LA - eng SI - ClinicalTrials.gov/NCT00220441 GR - KL2 RR025015/RR/NCRR NIH HHS/United States GR - KL2 RR025015-03/RR/NCRR NIH HHS/United States GR - UL1 TR000423/TR/NCATS NIH HHS/United States PT - Clinical Trial PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - Netherlands TA - J Alzheimers Dis JT - Journal of Alzheimer's disease : JAD JID - 9814863 RN - 0 (Amyloid beta-Peptides) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Aged MH - Alzheimer Disease/*etiology MH - Amyloid beta-Peptides/blood MH - Brain-Derived Neurotrophic Factor/blood MH - Cognition Disorders/*etiology/*rehabilitation MH - Executive Function/physiology MH - *Exercise MH - Exercise Therapy/*methods MH - Female MH - Follow-Up Studies MH - Glucose Clamp Technique/methods MH - Glucose Intolerance/*complications/rehabilitation MH - Heart Rate/physiology MH - Humans MH - Insulin-Like Growth Factor I/metabolism MH - Male MH - Memory/physiology MH - Middle Aged MH - Neuropsychological Tests MH - Oxygen Consumption/physiology MH - Risk Factors PMC - PMC3049111 MID - NIHMS267530 COIS- The authors have no conflict of interest to disclose. EDAT- 2010/09/18 06:00 MHDA- 2011/03/10 06:00 PMCR- 2011/03/05 CRDT- 2010/09/18 06:00 PHST- 2010/09/18 06:00 [entrez] PHST- 2010/09/18 06:00 [pubmed] PHST- 2011/03/10 06:00 [medline] PHST- 2011/03/05 00:00 [pmc-release] AID - 04172L5V1413114M [pii] AID - 10.3233/JAD-2010-100768 [doi] PST - ppublish SO - J Alzheimers Dis. 2010;22(2):569-79. doi: 10.3233/JAD-2010-100768.